Matches in Wikidata for { <http://www.wikidata.org/entity/Q90117020> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- Q90117020 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90117020 description "scientific article published on 06 March 2020" @default.
- Q90117020 description "wetenschappelijk artikel" @default.
- Q90117020 description "наукова стаття, опублікована 6 березня 2020" @default.
- Q90117020 name "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 name "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 type Item @default.
- Q90117020 label "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 label "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 prefLabel "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 prefLabel "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 P1433 Q90117020-03AE5B8B-CD22-41C6-83DB-17E26B339F4B @default.
- Q90117020 P1476 Q90117020-DF78234B-387D-48EA-9422-9B737F8136BD @default.
- Q90117020 P2093 Q90117020-108D93D3-E2BB-45B3-ABC9-5EFD33270D9B @default.
- Q90117020 P2093 Q90117020-159ABAD4-4AB8-445D-B3B9-AACB2266442A @default.
- Q90117020 P2093 Q90117020-1928AB88-A12B-4D9B-A1DB-A485FA4233B5 @default.
- Q90117020 P2093 Q90117020-19889650-4691-4FC5-BDD0-76302B002BAC @default.
- Q90117020 P2093 Q90117020-225A7786-B054-4B9F-8AEC-88654D614219 @default.
- Q90117020 P2093 Q90117020-228E6911-77DD-4529-8929-3FFC1421B4CF @default.
- Q90117020 P2093 Q90117020-3AA5354D-6C75-4B0E-8243-7A45B7C0AF25 @default.
- Q90117020 P2093 Q90117020-43AB3818-A6AF-48E4-AF84-FCD98A01A1D3 @default.
- Q90117020 P2093 Q90117020-717F2070-6FE1-420B-AC83-EF438E39F08E @default.
- Q90117020 P2093 Q90117020-8102009F-8534-4BCD-B1E9-020445EFAB88 @default.
- Q90117020 P2093 Q90117020-83F59677-8711-437A-AA0C-6A8D0E602B1E @default.
- Q90117020 P2093 Q90117020-9F4A8354-70F8-4EF0-B786-30BB1EF5E6BD @default.
- Q90117020 P2093 Q90117020-A0010499-61C4-4F0B-AD7C-C6E327C76ECD @default.
- Q90117020 P2093 Q90117020-A341C5F3-70D6-4025-BE47-7BBC4F1B39D8 @default.
- Q90117020 P2093 Q90117020-A7B958F0-3C31-4389-9E67-1C1DCD818FD8 @default.
- Q90117020 P2093 Q90117020-C641860E-24AF-4CC3-97E7-98B5802D7B92 @default.
- Q90117020 P2093 Q90117020-D8DCE53F-9B0B-4D02-9B77-32B5610E3604 @default.
- Q90117020 P2093 Q90117020-EB9442E9-DEB5-4800-8423-F8D0B1C3C759 @default.
- Q90117020 P2093 Q90117020-EE77F652-7C5D-4767-AC22-4DC172A71248 @default.
- Q90117020 P2093 Q90117020-EEA128FA-BFCB-4D1F-8756-AC5F63DC09AE @default.
- Q90117020 P31 Q90117020-590E5D2A-5CF8-4DCA-8DC2-EC6876A4BEB4 @default.
- Q90117020 P356 Q90117020-E3FEFD52-BB95-4C32-ABCA-BE7AF0303B6E @default.
- Q90117020 P50 Q90117020-03E6C4BA-AB1D-4AD3-9D01-BC5D3D5691E4 @default.
- Q90117020 P50 Q90117020-2988CC11-87C9-49AA-B630-780F7B124A69 @default.
- Q90117020 P50 Q90117020-61C997A2-4BE3-4D37-B842-0A64C3C3157B @default.
- Q90117020 P577 Q90117020-AB908BF9-7E35-467B-88CB-34CACCEB51FE @default.
- Q90117020 P698 Q90117020-050F83B0-FECE-4507-B332-8B0D3A8ADAEF @default.
- Q90117020 P921 Q90117020-FF5C1C7B-24B9-44BE-B9AD-9844316F4D2E @default.
- Q90117020 P356 1078-0432.CCR-19-3056 @default.
- Q90117020 P698 32144133 @default.
- Q90117020 P1433 Q332253 @default.
- Q90117020 P1476 "Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial" @default.
- Q90117020 P2093 "Anne Madroszyk-Flandin" @default.
- Q90117020 P2093 "Anne-Claire Toffart" @default.
- Q90117020 P2093 "Benjamin Besse" @default.
- Q90117020 P2093 "Bertrand Mennecier" @default.
- Q90117020 P2093 "Clarisse Audigier-Valette" @default.
- Q90117020 P2093 "Didier Debieuvre" @default.
- Q90117020 P2093 "Elodie Amour" @default.
- Q90117020 P2093 "Eric Pichon" @default.
- Q90117020 P2093 "Fabrice Barlesi" @default.
- Q90117020 P2093 "Franck Morin" @default.
- Q90117020 P2093 "Gérard Zalcman" @default.
- Q90117020 P2093 "Isabelle Monnet" @default.
- Q90117020 P2093 "Isabelle Rouquette" @default.
- Q90117020 P2093 "Olivier Molinier" @default.
- Q90117020 P2093 "Patrick Aldo Renault" @default.
- Q90117020 P2093 "Philippe Masson" @default.
- Q90117020 P2093 "Pierre Jean Souquet" @default.
- Q90117020 P2093 "Sandrine Hiret" @default.
- Q90117020 P2093 "Severine Fraboulet" @default.
- Q90117020 P2093 "Virginie Westeel" @default.
- Q90117020 P31 Q13442814 @default.
- Q90117020 P356 "10.1158/1078-0432.CCR-19-3056" @default.
- Q90117020 P50 Q57044198 @default.
- Q90117020 P50 Q57054866 @default.
- Q90117020 P50 Q63796091 @default.
- Q90117020 P577 "2020-03-06T00:00:00Z" @default.
- Q90117020 P698 "32144133" @default.
- Q90117020 P921 Q42824440 @default.